from Reuters: U.S. https://ift.tt/2QXYFcb
Tuesday, 20 November 2018
Home »
news
,
Reuters US
,
Reuters US news
,
Reuters: U.S.
» Trial spotlights U.S. drug safety concerns at compounding pharmacies
Trial spotlights U.S. drug safety concerns at compounding pharmacies
A top U.S. Food and Drug Administration official testified on Monday that the agency has concerns about drugs made by compounding pharmacies and still sees problems with them six years after a fungal meningitis outbreak tied to a Massachusetts pharmacy killed 76 people.

from Reuters: U.S. https://ift.tt/2QXYFcb
from Reuters: U.S. https://ift.tt/2QXYFcb
Related Posts:
'I wanna be dead': Teen obsessed with Columbine posted dark thoughts online(Editor's note: paragraph 4 contains language that readers may find offensive.) from Reuters: U.S. https://reut.rs/2v87jvw … Read More
Columbine principal, haunted by 20-year-old massacre, still recites victims' namesEach morning for the last two decades, Frank DeAngelis has recited aloud the names of the 13 people killed at Columbine High School, where he served as principal during the 1999 massacre that marked a modern era of mass schoo… Read More
U.S. authorities investigate American Airlines flight at JFK AirportThe U.S. National Transportation Safety Board (NTSB) said on Wednesday it is investigating an April 10 American Airlines flight at New York's John F. Kennedy International Airport that struck an object on takeoff and landed s… Read More
Carl's Jr to be first U.S. fast food chain to sell CBD-laced burgerCarl's Jr will become the first fast food chain to sell a CBD-infused hamburger when its "Rocky Mountain High Cheeseburger Delight" goes on sale in Denver on Saturday, the company said. from Reuters: U.S. https://reut.rs… Read More
Creditor group seeks to wrest probing power from Puerto Rico boardA group of public labor unions and other creditors on Wednesday asked a judge to grant it power to pursue probes into individuals who contributed to Puerto Rico's fiscal crisis because the U.S. commonwealth's federally create… Read More
0 comments:
Post a Comment